The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting

<table>Compound 1 50 mg/Kg X3 tandem dose (2.5 hr interval) predicted versus observed exposure.</table>

Journal of Drug Delivery

fig3

Figure 3

Figure 3: The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 

Figure 3 | The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 